Skip to main content

Table 4 Patient age impacts both ultrasound and mammography precision

From: The impact of breast cancer biological subtyping on tumor size assessment by ultrasound and mammography - a retrospective multicenter cohort study of 6543 primary breast cancer patients

Age (years) versus T stadium

pT1

pT2

pT3

<50

0.63591

0.33570

0.02839

50-70

0.63337

0.33754

0.02908

>70

0.46590

0.48902

0.04509

Age (years) versus Grading

G1

G2

G3

<50

0.095

0.530

0.375

50-70

0.122

0.627

0.251

>70

0.092

0.674

0.234

Age (years) versus HR expression

HR negative

HR incompletely responsive

HR positive

<50

0.20

0.23

0.57

50-70

0.14

0.21

0.65

>70

0.10

0.21

0.69

Age (years) versus HER2/neu expression

HER2/neu negative

HER2/neu positive

<50

0.82

0.18

50-70

0.85

0.15

>70

0.88

0.12

Age (years) versus histological subtype

Ductal invasive

Lobular invasive

<50

0.75

0.093

50-70

0.72

0.133

>70

0.71

0.128

Age (years)

HER2/neu negative

HER2/neu positive

<50

0.82

0.18

50-70

0.85

0.15

>70

0.88

0.12

  1. Relative Quantifications for T stadium, Grading, HR expression, HER2/neu expression or histological subtype in relation to age are shown